KURA ONCOLOGY, INC. — Net Income by Fiscal Year
19 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/6e746f14-59e3-4f55-826a-a7c88d27b998/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-278.7M | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-092567 |
| FY 2024 | $-174.0M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-029975 |
| FY 2023 | $-152.6M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-021094 |
| FY 2022 | $-135.8M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-004107 |
| FY 2021 | $-130.5M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-001967 |
| FY 2020 | $-89.6M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-007822 |
| FY 2019 | $-63.1M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-006391 |
| FY 2018 | $-60.4M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-006263 |
| FY 2017 | $-35.4M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-005293 |
| FY 2016 | $-27.6M | 2016-01-01 – 2016-12-31 | evidence 0001564590-17-004291 |
| FY 2015 | $-22.6M | 2015-01-01 – 2015-12-31 | evidence 0001564590-16-014998 |
| FY 2014 | $-30.7k | 2014-01-01 – 2014-12-31 | evidence 0001213900-15-001429 |
| FY 2013 | $-179.7k | 2007-11-16 – 2014-03-31 | evidence 0001213900-14-003353 |
| FY 2012 | $-151.3k | 2007-11-16 – 2013-03-31 | evidence 0001144204-13-029422 |
| FY 2011 | $-123.4k | 2007-11-16 – 2012-03-31 | evidence 0001144204-12-029113 |
| FY 2010 | $-22.4k | 2010-01-01 – 2010-12-31 | evidence 0001144204-12-018805 |
| FY 2009 | $-20.0k | 2009-01-01 – 2009-12-31 | evidence 0001144204-12-018805 |
| FY 2008 | $-33.6k | 2008-01-01 – 2008-12-31 | evidence 0001144204-12-018805 |
| FY 2007 | $-15.0k | 2007-01-01 – 2007-12-31 | evidence 0001213900-15-001429 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
KURA ONCOLOGY, INC. — all facts · Revenue · Operating Income